Celldex Therapeutics, Inc. Financial Ratios — CLDX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-43.09	-52.9	-34.51	-39.68	-43.44	-35.66	-26.62	-64.14	-36.51	-33.32	-20.72	-28.17	-34.56	-25.1	-37.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	1.58	3.81	43.23	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-423.51	-490.45	-1,909.44	-3,319.27	-2,290.69	-1,898.38	-816.27	-761.2	-1,390.06	-615.3	-1,420.77	-4,420.87	-2,019.96	-2,733.63	-18,381.04
Operating Margin (%)	-468.42	-518.45	-1,981.08	-3,414.11	-2,363.89	-1,958.68	-857.94	-801.05	-1,526.03	-668.27	-1,486.73	-4,543.74	-2,063.66	-2,778.89	-18,599.81
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-483.53	-527.79	-1,983.7	-3,292.81	-2,321.11	-1,894.05	-920.61	-1,593.09	-1,423.96	-821.61	-1,520.92	-4,765.59	-2,054.76	-2,248.76	-16,748.03
Profit Margin (%)	-483.53	-527.79	-1,983.7	-3,292.81	-2,321.11	-1,894.05	-730.06	-1,585.07	-1,423.96	-805.88	-1,516.04	-4,765.59	-2,054.76	-2,248.76	-16,748.03
Net Income to Common Margin (%)	-483.53	-527.79	-1,983.7	-3,292.81	-2,321.11	-1,894.05	-730.06	-1,585.07	-1,423.96	-805.88	-1,516.04	-4,765.59	-2,054.76	-2,248.76	-16,748.03
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	15	11	- -	3	4	- -	7	5	4	3	3	4	3	4	2
ST Debt	6	6	- -	3	4	- -	7	5	2	1	2	1	2	1	2
LT Debt	9	6	- -	- -	- -	- -	- -	- -	2	2	1	3	1	2	1
Total Debt/EBITDA	-0.39	-0.21	- -	-0.02	-0.04	- -	-0.06	-0.06	-0.07	-0.08	-0.05	-0.04	-0.02	-0.02	-0.01
Net Debt/EBITDA	-0.08	0.25	2.16	0.21	0.54	0.33	0.32	0.27	0.23	0.96	0.59	0.28	0.25	0.15	0.1
Total Debt/EBIT	-0.35	-0.2	- -	-0.02	-0.03	- -	-0.06	-0.06	-0.07	-0.07	-0.04	-0.04	-0.02	-0.02	-0.01
Net Debt/EBIT	-0.07	0.23	2.08	0.21	0.52	0.32	0.31	0.26	0.21	0.88	0.57	0.27	0.25	0.15	0.1
EBITDA to Interest Expense	-21.85	-34.86	-84.68	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-22.13	-35.05	-89.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-24.16	-36.85	-87.86	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	2	2	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-209.16	-210.34	-99.57	-186.95	-175.03	-187.65	-257.43	-617.7	-824.27	-455	-257.18	-356.04	-300.09	-196.27	-311.14
Long-Term Debt/Equity (%)	13.11	6	- -	- -	- -	- -	- -	- -	1.82	1.03	0.31	0.79	0.22	0.32	0.15
Long-Term Debt/Capital (%)	-4.75	-2.27	- -	- -	- -	- -	- -	- -	-0.17	-0.2	-0.11	-0.21	-0.07	-0.15	-0.04
Long-Term Debt/Total Assets (%)	9.19	4.58	- -	- -	- -	- -	- -	- -	1.39	0.91	0.29	0.73	0.2	0.3	0.13
Total Debt/Equity (%)	22.04	11.84	- -	1.22	1.52	- -	2.78	3.65	3.89	1.66	0.73	1.24	0.59	0.51	0.44
Total Debt/Capital (%)	-7.98	-4.49	- -	-0.56	-0.75	- -	-0.81	-0.47	-0.36	-0.33	-0.27	-0.32	-0.18	-0.25	-0.13
Total Debt/Total Assets (%)	15.45	9.03	- -	1.05	1.31	- -	2.08	2.9	2.97	1.48	0.68	1.14	0.55	0.48	0.4
Net Debt to Equity	4.72	-14.16	-52.97	-12.01	-23.33	-16	-14.27	-15.95	-11.95	-20.94	-9.33	-9.02	-8.11	-3.8	-5.48
Net Debt/Capital (%)	-1.61	4.88	32.89	5.2	10.28	5.57	3.98	2.01	1.1	3.94	3.32	2.3	2.44	1.8	1.57
EBITDA	-39	-55	-78	-119	-126	-129	-104	-73	-50	-46	-66	-104	-139	-192	-284
EBITDA-CapEx	-40	-55	-83	-121	-130	-132	-106	-73	-50	-47	-67	-106	-141	-194	-287
Operating Income (Loss)	-43	-58	-81	-122	-130	-133	-109	-76	-55	-50	-69	-107	-142	-195	-287

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.73	4.75	14.89	8.21	9.59	5.39	5.03	7.46	5.53	13.69	24.7	16.39	13.61	18.36	10.17
Current Ratio	3.82	4.81	15	8.37	9.75	5.55	5.22	7.86	5.73	13.93	24.86	17.07	13.87	18.91	10.49
Quick Ratio	3.74	4.75	14.91	8.23	9.62	5.44	5.09	7.71	5.62	13.81	24.71	16.41	13.69	18.38	10.21
CFO/Avg Current Liab	-2.07	-3.11	-3.56	-4.53	-3.61	-3.45	-3.17	-3.73	-3.83	-3.13	-3.96	-5.9	-4.31	-4.47	-4.66
Common Equity/Total Assets	-209.16	-210.34	-99.57	-186.95	-175.03	-187.65	-257.43	-617.7	-824.27	-455	-257.18	-356.04	-300.09	-196.27	-311.14
Long-Term Debt/Equity (%)	13.11	6	- -	- -	- -	- -	- -	- -	1.82	1.03	0.31	0.79	0.22	0.32	0.15
Long-Term Debt/Capital (%)	-4.75	-2.27	- -	- -	- -	- -	- -	- -	-0.17	-0.2	-0.11	-0.21	-0.07	-0.15	-0.04
Long-Term Debt/Total Assets (%)	9.19	4.58	- -	- -	- -	- -	- -	- -	1.39	0.91	0.29	0.73	0.2	0.3	0.13
Total Debt/Equity (%)	22.04	11.84	- -	1.22	1.52	- -	2.78	3.65	3.89	1.66	0.73	1.24	0.59	0.51	0.44
Total Debt/Capital (%)	-7.98	-4.49	- -	-0.56	-0.75	- -	-0.81	-0.47	-0.36	-0.33	-0.27	-0.32	-0.18	-0.25	-0.13
Total Debt/Total Assets (%)	15.45	9.03	- -	1.05	1.31	- -	2.08	2.9	2.97	1.48	0.68	1.14	0.55	0.48	0.4
CFO/Total Liabilities	-121.82	-167.24	-247.87	-279.3	-208.28	-95.85	-126.09	-236.97	-160.57	-152.58	-241.91	-390.98	-294.3	-348.03	-377.92
CFO/CapEx	-70.06	-164.3	-16.04	-52.64	-20.28	-41.09	-55.89	-92.54	-63.5	-26.03	-48.77	-56.75	-59.02	-82.22	-77.72
Altman's Z-Score	-3.71	2.75	41.16	23.09	16.2	-4.08	-5.8	-13.28	-19.92	4.76	36.24	41.88	27.21	18.97	14.16

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	109	104.69	15.43	7.83	7.85	4.93	6.96	3.78	1.71	5.27	4.71	9.08	4.63	4.22	1.14
Days Sales Outstanding	3.35	3.49	23.66	46.62	46.52	74.06	52.47	96.47	213.35	69.3	77.46	40.19	78.88	86.52	320.7
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	9.77	12.83	1.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	37.34	28.45	233.64	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	-34	-24.97	-209.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	3.35	3.49	23.66	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	103	387	1,931	1,632	1,522	359	365	31	32	519	1,656	2,090	1,921	1,627	1,804
- Cash & Cash Equivalents	12	25	169	28	72	42	40	24	11	44	39	29	35	28	29
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	15	11	- -	3	4	- -	7	5	4	3	3	4	3	4	2
Enterprise Value	65	315	1,628	1,433	1,236	170	232	-58	-28	328	1,251	1,789	1,500	906	1,288
Total Capital	-190	-253	-346	-461	-586	-719	-806	-958	-1,010	-1,070	-1,141	-1,252	-1,395	-1,551	-1,812
Total Debt/Capital (%)	-7.98	-4.49	- -	-0.56	-0.75	- -	-0.81	-0.47	-0.36	-0.33	-0.27	-0.32	-0.18	-0.25	-0.13
Total Debt / EV	0.23	0.04	- -	- -	- -	- -	0.03	-0.08	-0.13	0.01	- -	- -	- -	- -	- -
EV/Sales	6.97	28.09	396.11	399.63	225.6	25	18.22	- -	- -	44.26	269.04	758.96	217.99	129.03	833.52
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	103	387	1,931	1,632	1,522	359	365	31	32	519	1,656	2,090	1,921	1,627	1,804
Diluted Enterprise Value	106	374	1,762	1,606	1,454	317	331	12	25	479	1,620	2,064	1,889	1,603	1,777
EV per Share	24.51	81.77	306.18	240.45	191.08	25.06	27.1	- -	- -	11.08	29.19	38.15	30.97	14.07	19.39
TTM Sales	9	11	4	4	5	7	13	10	4	7	5	2	7	7	2
TTM EBITDA	-39	-55	-78	-119	-126	-129	-104	-73	-50	-46	-66	-104	-139	-192	-284
TTM Operating Income	-43	-58	-81	-122	-130	-133	-109	-76	-55	-50	-69	-107	-142	-195	-287
TTM Cash Flow to Firm	-34	-48	-67	-102	-99	-113	-100	-75	-46	-40	-61	-104	-107	-158	-211
TTM Free Cash Flow to Firm	-33	-48	-63	-100	-94	-110	-98	-74	-46	-39	-60	-102	-105	-156	-208

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-2.92	-7.83	-30.44	-16.38	-16.19	-3.26	-3.72	-0.42	-0.71	-13.37	-27.77	-20.51	-18.22	-10.44	-8.66
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	65	315	1,628	1,433	1,236	170	232	-58	-28	328	1,251	1,789	1,500	906	1,288
Low Price	30.75	39.75	102.15	161.4	151.65	42.75	33	2.7	2.01	1.5	15.37	19.85	22.11	22.93	14.4
EV/Sales	6.97	28.09	396.11	399.63	225.6	25	18.22	- -	- -	44.26	269.04	758.96	217.99	129.03	833.52
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-2.93	-4.9	-17.42	-13.51	-15.93	-3.87	-4.06	-1.09	-0.94	-4.55	-21.53	-13.29	-11.77	-14.66	-5.87
Price/Earnings High	-4.14	-7.03	-38	-25.23	-25.04	-12.33	-5.55	-3.19	-3.29	-11.6	-34.78	-19.22	-16.58	-21.69	-7.83
Price/Earnings Low	-1.81	-2.59	-6.66	-8.15	-7.71	-2.25	-3.04	-0.19	-0.57	-0.74	-9.34	-8.29	-7.57	-9.35	-3.7
Price/Book Value	-0.5	-1.47	-5.59	-3.52	-2.58	-0.5	-0.45	-0.03	-0.03	-0.48	-1.45	-1.66	-1.38	-1.05	-0.99
Price/Book Value Average	-0.64	-1.1	-4.11	-3.44	-3.43	-0.69	-0.47	-0.17	-0.05	-0.25	-1.33	-1.19	-1.19	-1.49	-0.84
Price/Book Value High	-0.91	-1.57	-8.97	-6.43	-5.39	-2.2	-0.64	-0.5	-0.17	-0.65	-2.14	-1.72	-1.68	-2.2	-1.12
Price/Book Value Low	-0.4	-0.58	-1.57	-2.07	-1.66	-0.4	-0.35	-0.03	-0.03	-0.04	-0.58	-0.74	-0.77	-0.95	-0.53
Price/Tangible Book Value	2.95	6.15	6.71	9.02	5.85	3.87	4.69	0.42	0.71	2.91	4.22	6.99	4.78	2.26	3.61
Price/Tangible Book Value Average	3.77	4.6	4.93	8.82	7.78	5.34	4.86	2.19	1.06	1.52	3.87	4.99	4.14	3.22	3.04
Price/Tangible Book Value High	5.33	6.6	10.76	16.47	12.23	17.05	6.64	6.4	3.7	3.88	6.25	7.22	5.83	4.76	4.05
Price/Tangible Book Value Low	2.32	2.43	1.89	5.32	3.77	3.11	3.63	0.37	0.64	0.25	1.68	3.11	2.66	2.05	1.91
Price/Sales	11.09	34.57	469.82	454.97	277.69	52.96	28.65	3.28	9.05	70	356.16	886.63	279.16	231.8	1,167.65
Price/Sales Average	14.16	25.84	345.52	444.77	369.71	73.21	29.67	17.32	13.4	36.65	326.35	633.54	241.93	329.77	982.97
Price/Sales High	20.04	37.09	753.72	830.92	581.25	233.55	40.55	50.58	46.9	93.5	527.23	915.88	340.68	487.82	1,311.24
Price/Sales Low	8.74	13.65	132.15	268.25	179.05	42.64	22.19	2.96	8.16	5.99	141.67	394.88	155.63	210.34	619.08
Price/Cash Flow	-2.88	-7.78	-28.54	-16.07	-15.39	-3.18	-3.65	-0.42	-0.7	-12.85	-27.2	-20.15	-17.91	-10.31	-8.55
Price/Cash Flow Average	-3.68	-5.81	-20.99	-15.71	-20.49	-4.39	-3.78	-2.2	-1.03	-6.73	-24.92	-14.4	-15.52	-14.67	-7.2
Price/Cash Flow High	-5.21	-8.35	-45.79	-29.35	-32.21	-14.02	-5.17	-6.41	-3.61	-17.17	-40.26	-20.81	-21.86	-21.7	-9.6
Price/Cash Flow Low	-2.27	-3.07	-8.03	-9.47	-9.92	-2.56	-2.83	-0.37	-0.63	-1.1	-10.82	-8.97	-9.98	-9.36	-4.53
Price/Free Cash Flow Average	-3.73	-5.85	-22.39	-16.01	-21.55	-4.5	-3.85	-2.22	-1.05	-7	-25.44	-14.65	-15.79	-14.85	-7.29
Price/Free Cash Flow High	-5.28	-8.4	-48.83	-29.91	-33.88	-14.37	-5.27	-6.48	-3.67	-17.85	-41.1	-21.18	-22.23	-21.97	-9.73
Price/Free Cash Flow Low	-2.3	-3.09	-8.56	-9.66	-10.44	-2.62	-2.88	-0.38	-0.64	-1.14	-11.04	-9.13	-10.16	-9.47	-4.59
EV/Sales Average	14.51	24.63	304.31	437.68	357.35	66.95	27.03	15.24	11.28	31.21	318.59	622.77	237.24	326.27	965.79
EV/Sales High	20.39	35.88	712.52	823.83	568.89	227.29	37.91	48.5	44.77	88.06	519.47	905.1	336	484.33	1,294.07
EV/Sales Low	9.09	12.44	90.95	261.16	166.7	36.38	19.55	0.88	6.04	0.55	133.91	384.1	150.94	206.84	601.9
EV/EBITDA Average	-3.43	-5.02	-15.94	-13.19	-15.6	-3.53	-3.31	-2	-0.81	-5.07	-22.42	-14.09	-11.74	-11.94	-5.25
EV/EBITDA High	-4.81	-7.32	-37.32	-24.82	-24.84	-11.97	-4.64	-6.37	-3.22	-14.31	-36.56	-20.47	-16.63	-17.72	-7.04
EV/EBITDA Low	-2.15	-2.54	-4.76	-7.87	-7.28	-1.92	-2.39	-0.12	-0.43	-0.09	-9.43	-8.69	-7.47	-7.57	-3.27
EV/EBIT Average	-3.1	-4.75	-15.36	-12.82	-15.12	-3.42	-3.15	-1.9	-0.74	-4.67	-21.43	-13.71	-11.5	-11.74	-5.19
EV/EBIT High	-4.35	-6.92	-35.97	-24.13	-24.07	-11.6	-4.42	-6.06	-2.93	-13.18	-34.94	-19.92	-16.28	-17.43	-6.96
EV/EBIT Low	-1.94	-2.4	-4.59	-7.65	-7.05	-1.86	-2.28	-0.11	-0.4	-0.08	-9.01	-8.45	-7.31	-7.44	-3.24
Last Price	39	100.65	363.15	273.75	235.2	53.1	42.6	3	2.23	17.52	38.64	44.57	39.66	25.27	27.16
High Price	70.5	108	582.6	499.95	492.3	234.15	60.3	46.2	11.55	23.4	57.2	46.04	48.4	53.18	30.5
Enterprise Value Average	134	276	1,251	1,570	1,958	454	344	145	40	232	1,482	1,468	1,633	2,290	1,492
Enterprise Value High	189	402	2,929	2,954	3,118	1,542	483	463	160	653	2,416	2,133	2,313	3,400	1,999
Enterprise Value Low	84	139	374	937	914	247	249	8	22	4	623	905	1,039	1,452	930

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	3	4	6	6	7	8	9	12	17	40	47	47	56	66	67
Diluted Weighted Avg Shares	3	4	5	6	6	7	9	10	15	30	43	47	48	64	66
Basic Weighted Avg Shares	3	4	5	6	6	7	9	10	15	30	43	47	48	64	66
Revenue per Share	3.52	2.91	0.77	0.6	0.85	1	1.49	0.91	0.25	0.25	0.11	0.05	0.14	0.11	0.02
EBITDA per Share	-14.9	-14.28	-14.76	-19.97	-19.4	-19.03	-12.14	-6.95	-3.42	-1.54	-1.54	-2.22	-2.87	-2.98	-4.28
Operating Income per Share	-16.48	-15.09	-15.31	-20.54	-20.02	-19.64	-12.76	-7.32	-3.76	-1.67	-1.61	-2.28	-2.93	-3.03	-4.33
Basic EPS, GAAP	-17.01	-15.37	-15.33	-19.81	-19.66	-18.99	-10.86	-14.48	-3.51	-2.02	-1.64	-2.4	-2.92	-2.45	-3.9
Basic EPS from Cont Ops	-17.01	-15.37	-15.33	-19.81	-19.66	-18.99	-10.86	-14.48	-3.51	-2.02	-1.64	-2.4	-2.92	-2.45	-3.9
Diluted EPS, GAAP	-17.01	-15.37	-15.33	-19.81	-19.66	-18.99	-10.86	-14.48	-3.51	-2.02	-1.64	-2.4	-2.92	-2.45	-3.9
Diluted EPS from Cont Ops	-17.01	-15.37	-15.33	-19.81	-19.66	-18.99	-10.86	-14.48	-3.51	-2.02	-1.64	-2.4	-2.92	-2.45	-3.9
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-13.54	-12.94	-12.72	-17.04	-15.28	-16.7	-11.66	-7.21	-3.2	-1.36	-1.42	-2.21	-2.21	-2.45	-3.18
Free Cash Flow per Basic Share	-13.73	-13.02	-13.52	-17.36	-16.04	-17.11	-11.87	-7.28	-3.25	-1.42	-1.45	-2.25	-2.25	-2.48	-3.22
Cash & Equivalents per Share	20.24	21.82	56.97	33.73	44.8	28.04	16.27	9	4.44	6.56	9.52	6.5	8.74	11.26	7.81
Book Value per Share	-77.83	-68.63	-64.98	-77.8	-91.32	-106.28	-94.81	-92.17	-69.85	-36.2	-26.68	-26.78	-28.84	-24.15	-27.31
Tangible Book Value per Share	13.23	16.37	54.15	30.35	40.24	13.74	9.08	7.22	3.13	6.03	9.15	6.38	8.3	11.18	7.53

Celldex Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)